Deka Bank Deutsche Girozentrale Concert Pharmaceuticals, Inc. Transaction History

Deka Bank Deutsche Girozentrale

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 04, 2020	SELL	$5.71 - $9.22 $42,254 - $68,228	-7,400 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$5.88 - $12.35 $43,512 - $91,390	-7,400 Reduced 50.0%	7,400 $46,000
Q2 2019 Aug 01, 2019	BUY	$9.44 - $13.12 $54,752 - $76,096	5,800 Added 64.44%	14,800 $174,000
Q1 2019 May 10, 2019	BUY	$12.07 - $17.54 $19,312 - $28,064	1,600 Added 21.62%	9,000 $143,000
Q4 2018 Feb 12, 2019	SELL	$11.25 - $16.17 $18,000 - $25,872	-1,600 Reduced 17.78%	7,400 $88,000
Q1 2018 May 03, 2018	BUY	$19.24 - $28.03 $173,160 - $252,270	9,000 New	9,000 $197,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.